Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Person

Maziar Mike Doustdar

Tracked across 3 events · 50 articles · First seen Sep 10, 2025 · Last active Sep 16, 2026

Sentiment
23
Attention
8
Events
3
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 60
Business
Impact: As CEO of Novo Nordisk, Maziar Mike Doustdar is leading the company's AI-driven innovation strategy, which could enhance his leadership reputation and the company's future growth.
Aug 10, 2026 · 7 articles
4 10
Business
Novo Nordisk and Anthropic announced a collaboration on September 16, 2026, aimed at accelerating the development of new medicines using Anthropic's Claude AI models and the Claude Science research workbench. The Danish drugmaker will initially…
Impact: Novo Nordisk president and CEO Maziar Mike Doustdar framed the partnership as central to the company's AI-driven healthcare ambition and R&D productivity goals.
Sep 16, 2026 · 20 articles
8 0
Regulatory
Impact: Maziar Mike Doustdar, president and CEO of Novo Nordisk, announced the United States — Food and Drug Administration's approval of the Wegovy pill, highlighting its convenience and effectiveness for patients.
Dec 22, 2025 · 23 articles
ERGEN INTELLIGENCE
Track Maziar Mike Doustdar live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.